PCSK9: a convertase that coordinates LDL catabolism
Open Access
- 1 April 2009
- journal article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 50, S172-S177
- https://doi.org/10.1194/jlr.r800091-jlr200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADLJournal of Lipid Research, 2009
- Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptorProceedings of the National Academy of Sciences of the United States of America, 2008
- Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primatesProceedings of the National Academy of Sciences of the United States of America, 2008
- Molecular basis for LDL receptor recognition by PCSK9Proceedings of the National Academy of Sciences of the United States of America, 2008
- Plasma PCSK9 levels are significantly modified by statins and fibrates in humansLipids in Health and Disease, 2008
- The self-inhibited structure of full-length PCSK9 at 1.9 Å reveals structural homology with resistin within the C-terminal domainProceedings of the National Academy of Sciences of the United States of America, 2007
- Molecular biology of PCSK9: its role in LDL metabolismTrends in Biochemical Sciences, 2007
- Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease riskJournal of Medical Genetics, 2006
- Mutations in PCSK9 cause autosomal dominant hypercholesterolemiaNature Genetics, 2003
- The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): Liver regeneration and neuronal differentiationProceedings of the National Academy of Sciences of the United States of America, 2003